ArticleCancers2022

External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study.

Jae Seung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.